Symbol | Exchange | Currency |
---|
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company’s products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Buy | Strong Buy | Strong Buy | Buy | Strong Sell |
Technical Indicators | Strong Buy | Strong Buy | Buy | Strong Buy | Sell |
Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
2.31 | 2.48 | 2.31 | -0.120 | -4.94% | 537.99K | NASDAQ | |||
2.35 | 3.53 | 1.938 | +0.480 | +25.67% | 29.43M | NASDAQ | |||
29.33 | 29.58 | 28.37 | +0.84 | +2.95% | 116.50K | NASDAQ | |||
32.38 | 32.81 | 31.51 | 0.00 | 0.00% | 760.52K | NASDAQ | |||
0.0136 | 0.015 | 0.0135 | -0.0004 | -2.86% | 5.45M | OTC Markets | |||
9.60 | 10.34 | 9.60 | -0.28 | -2.83% | 13.14K | NYSE | |||
82.80 | 84.30 | 82.31 | +0.44 | +0.53% | 235.19K | NASDAQ | |||
48.46 | 48.63 | 45.45 | +3.22 | +7.12% | 1.69M | NYSE | |||
137.09 | 137.42 | 134.06 | +1.15 | +0.85% | 5.61M | NASDAQ | |||
2.14 | 2.22 | 2.02 | +0.100 | +4.90% | 7.93M | NYSE | |||
94.19 | 94.32 | 90.33 | +4.46 | +4.97% | 4.52M | NASDAQ | |||
8.36 | 8.48 | 8.29 | +0.02 | +0.24% | 20.25K | NYSE | |||
0.843 | 0.99 | 0.843 | -0.035 | -3.93% | 3.81M | NYSE | |||
Saksderived | 16.05 | 16.05 | 16.02 | 0.00 | 0.00% | 0.00 | NYSE | ||
23.99 | 24.09 | 23.51 | +0.39 | +1.65% | 8.96M | NYSE |